ABOUT US
An immune insights company
Led by a highly collaborative team of clinical and medical technology innovators with operations based in St. Louis, MO and Dublin, Ireland.
About Kypha
Founded in 2010, Kypha has been driven by the desire to deliver clinically reliable tests for several biomarkers of immune activity, including many belonging to a major arm of the immune system, called complement.
Building on our success in complement testing, Kypha’s solutions and experience now support a bigger vision and much larger market opportunity. Kypha is uniquely positioned to create a new standard of care and be the global leader in unlocking the potential of immune insights in real time.
We continue to be extremely collaborative and proud of the extensive network of biopharma and clinical partners, customers and collaborators with whom we have built enduring relationships over the past decade.
Kypha has an extensive clinical collaborator network across several medical specialties and laboratory medicine to support clinical trials as well as identify and validate additional immune biomarkers across multiple therapeutic areas.
Measuring changes in immune activity biomarker levels helps physicians detect and follow disease progression or determine treatment effectiveness.
photo_auto_merge
Our Leadership
Kypha has assembled an impressive team that has proven experience, knowledge, and performance gained through employment with Fortune 500, private, and entrepreneurial companies. The team has a diverse spectrum of expertise, skill sets, and industry credentials that impact across key functional areas of the business – science, development, operations, and commercialization. These are some of our leadership team members:
